Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc.

NASDAQ:RVPH

Overview | Financials
Company Name Reviva Pharmaceuticals Holdings, Inc.
Symbol RVPH
Currency USD
Price 1.58
Market Cap 73,595,136
Dividend Yield 0%
52-week-range 0.6 - 4.83
Industry Biotechnology
Sector Healthcare
CEO Dr. Laxminarayan Bhat Ph.D.
Website https://revivapharma.com

An error occurred while fetching data.

About Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment

Related Stocks

Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc.

MRKR

2.54 USD

Acurx Pharmaceuticals, Inc. logo

Acurx Pharmaceuticals, Inc.

ACXP

0.699 USD

Precipio, Inc. logo

Precipio, Inc.

PRPO

6.06 USD

Healthcare Triangle, Inc. logo

Healthcare Triangle, Inc.

HCTI

0.938 USD

Financials

Numbers are in millions USD

Numbers are in millions USD